AB
Amalgamated Bank’s NovoCure NVCR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $66K | Hold |
3,729
| – | – | ﹤0.01% | 1773 |
|
2025
Q1 | $66K | Buy |
3,729
+13
| +0.3% | +$230 | ﹤0.01% | 1748 |
|
2024
Q4 | $111K | Hold |
3,716
| – | – | ﹤0.01% | 1684 |
|
2024
Q3 | $58K | Hold |
3,716
| – | – | ﹤0.01% | 1805 |
|
2024
Q2 | $64K | Sell |
3,716
-3,173
| -46% | -$54.6K | ﹤0.01% | 1805 |
|
2024
Q1 | $108K | Sell |
6,889
-14,174
| -67% | -$222K | ﹤0.01% | 1712 |
|
2023
Q4 | $314K | Sell |
21,063
-2,784
| -12% | -$41.5K | ﹤0.01% | 1629 |
|
2023
Q3 | $385K | Buy |
23,847
+1,072
| +5% | +$17.3K | ﹤0.01% | 1539 |
|
2023
Q2 | $945K | Buy |
22,775
+1,122
| +5% | +$46.6K | 0.01% | 1147 |
|
2023
Q1 | $1.3M | Sell |
21,653
-2,136
| -9% | -$128K | 0.01% | 1015 |
|
2022
Q4 | $1.75M | Buy |
23,789
+155
| +0.7% | +$11.4K | 0.02% | 947 |
|
2022
Q3 | $1.8M | Buy |
23,634
+398
| +2% | +$30.2K | 0.02% | 886 |
|
2022
Q2 | $1.62M | Buy |
23,236
+11,679
| +101% | +$812K | 0.02% | 944 |
|
2022
Q1 | $957K | Buy |
+11,557
| New | +$957K | 0.01% | 1220 |
|
2020
Q4 | – | Sell |
-20,102
| Closed | -$2.24M | – | 1595 |
|
2020
Q3 | $2.24M | Sell |
20,102
-513
| -2% | -$57.1K | 0.1% | 165 |
|
2020
Q2 | $1.22M | Buy |
20,615
+5,262
| +34% | +$312K | 0.06% | 338 |
|
2020
Q1 | $1.03M | Sell |
15,353
-511
| -3% | -$34.4K | 0.03% | 610 |
|
2019
Q4 | $1.34M | Buy |
15,864
+863
| +6% | +$72.7K | 0.02% | 684 |
|
2019
Q3 | $1.12M | Sell |
15,001
-190
| -1% | -$14.2K | 0.02% | 701 |
|
2019
Q2 | $961K | Buy |
15,191
+4,037
| +36% | +$255K | 0.02% | 770 |
|
2019
Q1 | $537K | Buy |
11,154
+450
| +4% | +$21.7K | 0.01% | 966 |
|
2018
Q4 | $358K | Buy |
10,704
+6,394
| +148% | +$214K | 0.01% | 1087 |
|
2018
Q3 | $226K | Sell |
4,310
-6,648
| -61% | -$349K | 0.01% | 1260 |
|
2018
Q2 | $343K | Buy |
+10,958
| New | +$343K | 0.01% | 1236 |
|